|
TTLL4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64510000066898E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.164000E-04 |
| Normal-vs-Stage2 |
4.497900E-03 |
| Normal-vs-Stage3 |
5.214600E-04 |
| Normal-vs-Stage4 |
3.865500E-02 |
| Stage1-vs-Stage2 |
8.252000E-02 |
| Stage1-vs-Stage3 |
2.380300E-02 |
| Stage1-vs-Stage4 |
1.675030E-01 |
| Stage2-vs-Stage3 |
8.243600E-01 |
| Stage2-vs-Stage4 |
8.035400E-01 |
| Stage3-vs-Stage4 |
9.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83140000054038E-07 |
| Normal-vs-AfricanAmerican |
1.223090E-04 |
| Normal-vs-Asian |
1.560390E-01 |
| Caucasian-vs-AfricanAmerican |
8.971400E-01 |
| Caucasian-vs-Asian |
4.056200E-01 |
| AfricanAmerican-vs-Asian |
4.671800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15950000004295E-06 |
| Normal-vs-Female |
3.42579997703041E-09 |
| Male-vs-Female |
9.383700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.585500E-04 |
| Normal-vs-Extreme_Weight |
1.862630E-03 |
| Normal-vs-Obese |
2.22759999999322E-05 |
| Normal-vs-Extreme_Obese |
1.712760E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.813820E-01 |
| Normal_Weight-vs-Obese |
4.228800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.753800E-01 |
| Extreme_Weight-vs-Obese |
1.931550E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.727800E-01 |
| Obese-vs-Extreme_Obese |
2.834400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.983700E-04 |
| Normal-vs-Age(41-60Yrs) |
7.05250002841495E-09 |
| Normal-vs-Age(61-80Yrs) |
8.05690000000858E-05 |
| Normal-vs-Age(81-100Yrs) |
5.393800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.436100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.63710000000395E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.649100E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.450100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.893540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.859200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.1300000000446E-06 |
| Normal-VS-Type2 PRCC |
3.963900E-03 |
| Normal-VS-KIRP CIMP |
3.398900E-04 |
| Normal-VS-Unclassified PRCC |
1.69029999996795E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.997800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.13029999804226E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
1.483390E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.04259999978274E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
2.360500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.958600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.117000E-03 |
| Normal-vs-N1 |
1.96818000000043E-05 |
| Normal-vs-N2 |
3.4746999999502E-06 |
| N0-vs-N1 |
5.577000E-04 |
| N0-vs-N2 |
3.431600E-02 |
| N1-vs-N2 |
1.833040E-01 |
|
|
